Emma Walmsley, CEO - gsk.com

Agenda 2 Q2 2018 progress (15 mins) Emma Walmsley, Chief Executive Officer Q2 2018 financial results (15 mins) Simon Dingemans, Chief Financial Officer

  Mame

Audit & Risk Committee Terms of Reference - Home | GSK

Audit & Risk Committee – Terms of Reference 2 3. Each of the members of the Committee shall be independent Non-Executive Directors, as determined by the Board of the Company, in accordance with the provisions of the UK Corporate

  Terms, Risks, Reference, Committees, Audit, Terms of reference audit amp risk committee

Q3 2021 results

Progressing towards demerger at pace. 8. 1. All outlook and ambition statements are given on a constant currency basis and use 2021 forecast exchange rates as a base, assuming a continuation of Q1 2021 closing rates. 2021-26 CAGR is for the 5 …

Press release Second quarter 2021

All expectations, guidance and targets regarding future performance and dividend payments should be read together with ‘Outlook, assumptions and cautionary statements’ on pages 68 and 69. If exchange rates were to hold at the closing rates on 30 June 2021 ($1.39/£1, €1.17/£1 and Yen 153/£1) for the rest of 2021, the

  Dividend, And dividends

Press release Third quarter 2021

Issued: Wednesday, 27 October 2021, London, U.K. 3 Operating performance – Q3 2021 Turnover Q3 2021 £m Growth £% Growth CER% Pharmaceuticals 4,397 5 10 Vaccines 2,174 7 13 Consumer Healthcare 2,506 3 8 Group turnover 9,077 5 10 Group turnover was £9,077 million in the quarter, up 5% AER, 10% CER.

  October, 27 october

Annual Report 2018 - GSK

GSK Annual Report 2018 02. Research & development . Success in R&D will always be fundamental to shareholder returns. A renewed focus on R&D was set out by Emma Walmsley when she became CEO in 2017, and a new plan to improve the pipeline of new medicines has now been launched by Dr Hal Barron, our new Chief

  Annual, Report, 2018, 2018 annual report, Gsk annual report 2018

Press release Full year and fourth quarter 2020 - GSK

* Reported AER and CER growth rates for 2020 include five months’ results of the former Pfizer consumer healthcare business in 2019. Pro-forma CER growth rates are calculated as if the equivalent seven months of Pfizer consumer healthcare business results, as reported by Pfizer, were included in the comparative period of 2019.

  Pfizer

Annual Report 2019 - GSK

Trust We are a responsible company and commit to use our science and technology to address health needs, make our products affordable and available and to be a modern employer. Our values and expectations Our values – patient focus, transparency, respect and integrity. Our expectations – courage, accountability, development and teamwork.

  Trust, Annual, Report, Annual report, Affordable

Annual Report 2020 - GSK

framework, we invest in our business to provide shareholder returns. In 2020 we paid a dividend of 80p per share and delivered £5.4 billion of free cash flow. We make a positive contribution to the communities in . which we operate. We employ over 94,000 people across 96 countries and work directly with 36,000 suppliers.

  Annual, Report, Return, 2200, Shareholders, 2002 annual report, Shareholder returns

ESG Performance Summary 2020 - GSK

Employee turnover Overall turnover (%) – – 12.5 15.7 Calculated as the number of permanent employees that left GSK in 2020 for any reason divided by the average 2020 permanent headcount. Turnover of voluntary leavers (%) – – 6.7 5.6 Calculated as the number of permanent employees that voluntarily left GSK in 2020

  Performance, Employee, Summary, 2200, Turnover, Employee turnover, Esg performance summary 2020

Special Considerations—Audits of Financial Statements ...

bered and amended,effective for audits of financial statements prepared in accordance with a special purpose framework for periods ending on or after December15,2021,bySASNo.139.] Alerting Readers in an Emphasis-of-Matter Paragraph That the Financial Statements Are Prepared in Accordance With a Special Purpose Framework (Ref: par. .A31)

  Testament, Special, Financial, Audit, Prepared, Considerations, Financial statements, Accordance, Prepared in accordance, Special considerations audits of financial statements, Financial statements prepared in accordance

INTERNATIONAL STANDARD ON AUDITING 800 SPECIAL ...

Financial statements prepared in accordance with a special purpose framework may be the only financial statements an entity prepares. In such circumstances, those financial statements may be used by users other than those for whom the …

  Testament, Financial, Prepared, Financial statements, Accordance, Financial statements prepared in accordance

Compilation and Review Reports on Financial Statements ...

Below are illustrative accountant’s compilation and review reports on financial statements prepared in accordance with IFRS for Small and Medium-sized Entities. For more information, see Interpretation No. 13 to AR section 80 and Interpretation No. 8 to AR section 90. Accountant’s Compilation Report [Appropriate Salutation] I (we) have ...

  Testament, Financial, Prepared, Financial statements, Accordance, Financial statements prepared in accordance

Preparation of Financial Statements

Preparation of Financial Statements 4477 AR-CSection70 Preparation of Financial Statements Source:SSARSNo.21;SSARSNo.23;SSARSNo.25. ... tive financial information prepared and presented in accordance with other ... in accordance with accounting principles generally accepted in the United

  Testament, Financial, Prepared, Financial statements, Accordance, In accordance

Examples of Auditors’ Reports on Financial Statements

The financial statements have been prepared in accordance with the tax basis of accounting in Country X to assist the partners of ABC Partnership in preparing their individual income tax returns. The financial statements and related auditor’s re port may not be suitab le …

  Report, Testament, Financial, Prepared, Financial statements, Auditors, Accordance, Prepared in accordance, Auditors reports on financial statements

Financial statements - BP

• The financial statements have been prepared in accordance with the requirements of the Companies Act 2006 and, as regards the group financial statements, Article 4 of the IAS Regulation. We have audited the financial statements of BP p.l.c. which comprise the: • Group income statement; • Group statement of comprehensive income;

  Testament, Financial, Prepared, Financial statements, Accordance, Prepared in accordance

FINANCIAL STATEMENTS - Coca-Cola FEMSA

FINANCIAL STATEMENTS 1 Annual Report of the Audit Committee 2 ... dence requirements for each member in accordance with the rules applicable in this matter. The work carried out by the Committee was duly documented in the prepared minutes of each session, which were reviewed and approved in a timely

  Testament, Financial, Prepared, Financial statements, Accordance, In accordance

FINANCIAL STATEMENTS For FANCY TECHNOLOGIES …

PREPARED WITHOUT AUDIT. FANCY TECHNOLOGIES LIMITED NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED JULY 31, 2013. 1. 2. Page 5 of 10. Revenue recognition policies are an important part of accrual basis accounting. The notes to the financial statements provide background and added disclosures and are

  Testament, Financial, Technologies, Prepared, Financial statements, Fancy, Financial statements for fancy technologies